PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

PAR. SP, page-998

  1. 422 Posts.
    lightbulb Created with Sketch. 84
    Holdup because communications with FDA have been in similar style to PAR comms to shareholders. That leads to a lot of questions that PAR or its contractors have to answer. It also makes the FDA check and double check everything PAR says. All that takes time alas - and it would be very naive to put all the blame for the delays on the FDA.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.